(77 days)
Not Found
Not Found
No
The device description and performance studies focus on the physical characteristics and mechanical performance of a balloon catheter, with no mention of AI or ML algorithms for image analysis, decision support, or any other function.
Yes
The device, named MTI HyperGlide™ Occlusion Balloon Catheter, is indicated for temporary occlusion in blood vessels to stop or control blood flow, which is a therapeutic intervention.
No
The device is an occlusion balloon catheter used to temporarily stop or control blood flow, which is a therapeutic function, not diagnostic. While it uses angiographic visualization for placement, its primary purpose is not to diagnose a condition.
No
The device description clearly details a physical catheter with a balloon, guidewire, and platinum markers, indicating it is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body (like blood, urine, or tissue) to detect diseases, conditions, or infections.
- Device Function: The MTI HyperGlide™ Occlusion Balloon Catheter is a medical device used within the body (in vivo) to temporarily stop or control blood flow in blood vessels. It is a therapeutic and interventional device, not a diagnostic test performed on samples outside the body.
- Intended Use: The intended use clearly describes a procedure performed directly on the patient's vasculature.
- Device Description: The description details a physical catheter with a balloon designed for insertion into blood vessels.
- Input Imaging Modality: Angiographic visualization is used to guide the placement of the device within the body, not to analyze samples.
Therefore, the MTI HyperGlide™ Occlusion Balloon Catheter falls under the category of an interventional medical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The MTI HyperGlide™ Occlusion Balloon Catheter is indicated for use in the blood vessels of the peripheral and neuro vasculature where temporary occlusion is desired. The MTI Occlusion Balloon Catheter offers a vessel selective technique of temporary vascular occlusion, which is useful in selectively stopping or controlling blood flow.
Product codes (comma separated list FDA assigned to the subject device)
MJN
Device Description
The HyperGlide™ Occlusion Balloon Catheter is a single lumen balloon catheter with at maximum outer diameter of 2.8F tapering to 2.2F at the distal tip. The distal end of the catheter has a non-detachable low inflation pressure compliant balloon. The catheter is designed to track over the MTI 0.010" guidewire, and requires insertion of the guidewire to occlude the catheter shaft lumen to allow inflation of the balloon. Two platinum markers provide angiographic visualization of the balloon length and facilitate intravascular placement of the balloon prior to inflation. The catheter shaft is hydrophilically coated to assist catheter advancement within the vasculature. The HyperGlide catheter is supplied sterile for single use or as a system, which includes the required 0.010" guidewire.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
blood vessels of the peripheral and neuro vasculature
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing of the HyperGlide catheter was conducted in accordance with ISO 10555 Sterile, Single Use Intravascular Catheters- Parts 1 and 4 and Guidance for the Submission of Research and Marketing Applications for Interventional Cardiology Devices: PTCA Catheters, Atherectomy Catheters , Lasers, and Intravascular Stents (Draft May 1995).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
MTI Equinox™ Occlusion Balloon Catheter
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4450 Vascular clamp.
(a)
Identification. A vascular clamp is a surgical instrument used to occlude a blood vessel temporarily.(b)
Classification. Class II (performance standards).
0
| Micro Therapeutics, Inc. |
|---|
| Special 510(k): HyperGlide™ Occlusion Balloon Catheter |
Attachment 4
510(k) Summary
Prepared March 28, 2002
| TRADE NAME | HyperGlide™ Occlusion Balloon Catheter |
|---|---|
| GENERIC NAME | Occlusion Balloon Catheter |
| CLASSIFICATION | |
| SUBMITTED BY | Class II (21 CFR 870.4450) |
| Micro Therapeutics, Inc. | |
| 2 Goodyear | |
| Irvine, CA 92618 | |
| CONTACT Tom Daughters | |
| Regulatory Affairs | |
| (949) 837-3700 | |
| PREDICATE DEVICE | MTI Equinox™ Occlusion Balloon Catheter |
| DEVICE DESCRIPTION | MTI HyperGlide™ Occlusion Balloon Catheter |
| The HyperGlide™ Occlusion Balloon Catheter is a single lumen balloon | |
| catheter with at maximum outer diameter of 2.8F tapering to 2.2F at the | |
| distal tip. The distal end of the catheter has a non-detachable low inflation | |
| pressure compliant balloon. The catheter is designed to track over the MTI | |
| 0.010" guidewire, and requires insertion of the guidewire to occlude the | |
| catheter shaft lumen to allow inflation of the balloon. Two platinum | |
| markers provide angiographic visualization of the balloon length and | |
| facilitate intravascular placement of the balloon prior to inflation. The | |
| catheter shaft is hydrophilically coated to assist catheter advancement | |
| within the vasculature. The HyperGlide catheter is supplied sterile for | |
| single use or as a system, which includes the required 0.010" guidewire. | |
| INDICATIONS FOR USE | The MTI Occlusion Balloon Catheter is indicated for use in the blood |
| vessels of the peripheral and neuro vasculature where temporary occlusion | |
| is desired. The MTI Occlusion Balloon Catheter offers a vessel selective | |
| technique of temporary vascular occlusion, which is useful in selectively | |
| stopping or controlling blood flow. | |
| TESTING | Performance testing of the HyperGlide catheter was conducted in |
| accordance with ISO 10555 Sterile, Single Use Intravascular Catheters- | |
| Parts 1 and 4 and Guidance for the Submission of Research and Marketing | |
| Applications for Interventional Cardiology Devices: PTCA Catheters, | |
| Atherectomy Catheters , Lasers, and Intravascular Stents (Draft May 1995). | |
| SUMMARY OF | |
| SUBSTANTIAL | |
| EQUIVALENCE | The MTI HyperGlide™ Occlusion Balloon Catheter is substantially |
| equivalent to the predicate device in intended use, principles of operation | |
| and performance. |
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized human profiles facing to the right.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 1 8 2002
Mr. Tom Daughters Director of Regulatory Affairs Micro Therapeutics, Inc. 2 Goodyear Irvine, CA 92618
Re: K021066
Trade/Device Name: MTI HyperGlide™ Occlusion Balloon Catheter Regulation Number: 870.4450 Regulation Name: Vascular clamp Regulatory Class: II Product Code: MJN Dated: March 28, 2002 Received: April 2, 2002
Dear Mr. Daughters:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Mr. Tom Daughters
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sincerely yours,
Mark N Milken
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Micro Therapeutics, Inc.
Special 510(k): HyperGlide™ Occlusion Balloon Catheter
KO21066
Attachment 2
Indications for Use Statement
510(k) Number (if known): ______________
Device Name:
MTI HyperGlide™ Occlusion Balloon Catheter
The MTI HyperGlide™ Occlusion Balloon Catheter is Indications for Use: indicated for use in the blood vessels of the peripheral and neuro vasculature where temporary occlusion is desired. The MTI Modified Occlusion Balloon Catheter offers a vessel selective technique of temporary vascular occlusion, which is useful in selectively stopping or controlling blood flow.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use | X | OR | Over the Counter Use | |
|---|---|---|---|---|
| ------------------ | --- | ---- | ---------------------- | -- |
(Per 21 CFR 801.109)
(Division Sign-Off)
Division of General, Restorative and Neurological Devices
Page 20 of 24